Immune activation requires a certain period to manifest clinically, immune checkpoint inhibitors (e.g., PD-1/PD-L1 inhibitors) exert anti-tumor effects by activating T cells, a process that may take weeks to months. The gene discussed is CD274; the disease is neoplasm.